Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Koller

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Advanced Drug Delivery Reviews|March 25, 2024
Challenges and progress related to gene editing in rare skin diseasesJosefina Piñón Hofbauer, Christina Guttmann-Gruber, Verena Wally, et al.
Journal of Clinical Medicine|April 26, 2020
Radiofrequency Chondroplasty May Not Have A Long-Lasting Effect in the Treatment of Concomitant Grade II Patellar Cartilage Defects in HumansUlrich Koller, Bernhard Springer, Colleen Rentenberger, et al.
The American Journal of Sports Medicine|March 26, 2014
Treatment of Full-Thickness Chondral Defects With Hyalograft C in the Knee: Long-term ResultsMartin O Brix, David Stelzeneder, Catharina Chiari, et al.
International Journal of Molecular Sciences|September 27, 2016
Designing Efficient Double RNA trans-Splicing Molecules for Targeted RNA RepairClemens Hüttner, Eva M Murauer, Stefan Hainzl, et al.
Molecular Therapy. Nucleic Acids|November 1, 2019
Improved Double-Nicking Strategies for COL7A1-Editing by Homologous RecombinationThomas Kocher, Roland N Wagner, Alfred Klausegger, et al.
The Journal of Investigative Dermatology|November 9, 2007
5' trans-splicing repair of the PLEC1 geneVerena Wally, Alfred Klausegger, Ulrich Koller, et al.
International Journal of Molecular Sciences|January 21, 2022
Transcriptome-Guided Drug Repurposing for Aggressive SCCsRoland Zauner, Monika Wimmer, Sonja Dorfer, et al.
Molecular Oncology|September 4, 2013
The design and optimization of RNA trans-splicing molecules for skin cancer therapyChristina Gruber, Ulrich Koller, Eva M Murauer, et al.
The Journal of Investigative Dermatology|March 7, 2020
Predictable CRISPR/Cas9-Mediated COL7A1 Reframing for Dystrophic Epidermolysis BullosaThomas Kocher, Oliver Patrick March, Johannes Bischof, et al.
Molecular Cancer Therapeutics|January 7, 2011
Spliceosome-mediated RNA trans-splicing facilitates targeted delivery of suicide genes to cancer cellsChristina Gruber, Iris K Gratz, Eva M Murauer, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Advanced Drug Delivery Reviews|March 25, 2024
Challenges and progress related to gene editing in rare skin diseasesJosefina Piñón Hofbauer, Christina Guttmann-Gruber, Verena Wally, et al.
Journal of Clinical Medicine|April 26, 2020
Radiofrequency Chondroplasty May Not Have A Long-Lasting Effect in the Treatment of Concomitant Grade II Patellar Cartilage Defects in HumansUlrich Koller, Bernhard Springer, Colleen Rentenberger, et al.
The American Journal of Sports Medicine|March 26, 2014
Treatment of Full-Thickness Chondral Defects With Hyalograft C in the Knee: Long-term ResultsMartin O Brix, David Stelzeneder, Catharina Chiari, et al.
International Journal of Molecular Sciences|September 27, 2016
Designing Efficient Double RNA trans-Splicing Molecules for Targeted RNA RepairClemens Hüttner, Eva M Murauer, Stefan Hainzl, et al.
Molecular Therapy. Nucleic Acids|November 1, 2019
Improved Double-Nicking Strategies for COL7A1-Editing by Homologous RecombinationThomas Kocher, Roland N Wagner, Alfred Klausegger, et al.
The Journal of Investigative Dermatology|November 9, 2007
5' trans-splicing repair of the PLEC1 geneVerena Wally, Alfred Klausegger, Ulrich Koller, et al.
International Journal of Molecular Sciences|January 21, 2022
Transcriptome-Guided Drug Repurposing for Aggressive SCCsRoland Zauner, Monika Wimmer, Sonja Dorfer, et al.
Molecular Oncology|September 4, 2013
The design and optimization of RNA trans-splicing molecules for skin cancer therapyChristina Gruber, Ulrich Koller, Eva M Murauer, et al.
The Journal of Investigative Dermatology|March 7, 2020
Predictable CRISPR/Cas9-Mediated COL7A1 Reframing for Dystrophic Epidermolysis BullosaThomas Kocher, Oliver Patrick March, Johannes Bischof, et al.
Molecular Cancer Therapeutics|January 7, 2011
Spliceosome-mediated RNA trans-splicing facilitates targeted delivery of suicide genes to cancer cellsChristina Gruber, Iris K Gratz, Eva M Murauer, et al.
Pageof 8